Takeda Xefo Injection Vial 8 mg is a medicine registered with the Saudi Food and Drug Authority. It contains the active ingredient Lornoxicam 8 mg, and its pharmaceutical form is powder and solvent for solution for injection. This medicine is available on prescription only.
Medicine Details
- Registered Trade Name: XEFO 8MG Powder for injection
- Active Ingredient and Strength: Lornoxicam 8 mg
- Pharmaceutical Form: Powder and Solvent for Solution for Injection
- Route of Administration: Intravenous
- Marketing Authorisation Holder: Jazeera Pharmaceutical Industries (JPI) (Saudi Arabia)
- ATC Classification Code: M01AC05
Prescription Requirement
This medicine is dispensed only against a valid prescription from a licensed doctor. When ordering from the store, upload a prescription image for the pharmacist to review before preparing the order. The dose and duration of use are determined solely by the treating doctor.
Storage
Store at room temperature not exceeding 25 degrees Celsius. Keep out of reach of children.
Registration Information
Registered with the Saudi Food and Drug Authority under number 3006222294.
The information above provides identification details from the Saudi Food and Drug Authority register and does not replace the treating doctor's instructions, the patient leaflet, or consultation with a pharmacist.